Jaguar Animal Health

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31
Revenue
$3,108
$2,721
$2,351
Gross Profit
2,567
2,294
1,311
EBITDA
-7,262
-6,638
-8,147
EBIT
-7,858
-7,197
-8,757
Net Income
-9,854
-9,492
-9,226
Net Change In Cash
3,108
2,721
2,351
Free Cash Flow
-6,325
-8,186
-7,047
Cash
13,269
16,049
11,671
Basic Shares
9,370
2,349
2,647

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$9,761
$11,956
$4,335
$9,385
Gross Profit
7,724
9,937
2,002
6,105
EBITDA
-33,131
-33,380
-42,352
-28,737
EBIT
-34,291
-35,672
-44,179
-31,017
Net Income
-41,300
-47,454
-60,251
-36,791
Net Change In Cash
9,761
11,956
4,335
9,385
Cost of Revenue
4,207
Free Cash Flow
-33,241
-34,779
-34,976
-15,285
Cash
6,469
5,469
17,051
8,090
Basic Shares
384
1,311
596
171

Earnings Calls

Quarter EPS
2024-09-30
-$1.05
2024-06-30
-$4.04
2024-03-31
-$0.07
2023-12-31
-$33